Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.
about
Costing of National STI Program Implementation for the Global STI Control Strategy for the Health Sector, 2016-2021.Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review.Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.Future microfluidic and nanofluidic modular platforms for nucleic acid liquid biopsy in precision medicine.Clinical Performance Validation of 4 Point-of-Care Cervical Cancer Screening Tests in HIV-Infected Women in Zambia.Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study.Scale-Up of an Human Papillomavirus Testing Implementation Program in El Salvador.The Global Health Service Partnership: An Academic-Clinical Partnership to Build Nursing and Medical Capacity in Africa.The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.Management algorithms for cervical cancer screening and precancer treatment for resource-limited settings.Cost-effectiveness analysis study of HPV testing as a primary cervical cancer screening in Thailand.Cervical Cancer Awareness among Women in Tanzania: An Analysis of Data from the 2011-12 Tanzania HIV and Malaria Indicators Survey.Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.Opportunities and challenges for introducing HPV testing for cervical cancer screening in sub-Saharan Africa
P2860
Q29247953-4239DF31-007D-4155-851B-E07BBCF068EAQ30235262-E17E0FA0-4946-4C57-888A-15AB10933BCEQ30251868-B916265A-B155-4E4A-B133-3C14CA062A4FQ30357091-42A3B794-B1D0-4122-8DFE-C199893B05CAQ37037325-8BD3EEF1-C2C8-484E-964D-ECDB8484E4A3Q37314466-87254412-4A83-4B5A-A094-79C8D8445B6AQ37546697-1F593D48-9468-4219-ADBF-6A94B4E44FB0Q38645119-E9DD31C5-F36E-4823-B569-408422064DD8Q38687001-DDB1D270-6B78-46AA-80C0-8C7089F36879Q40129828-F541E6D6-F019-44FB-9416-0EE9BBC9C772Q42373449-A3EE87E3-F807-4013-8D80-EE9304F0D6E1Q55246544-1716165A-92A5-4871-868D-4DC57D425E49Q55384416-08F1DC8A-08E9-4D52-9ED9-0D6BBD4827F4Q55466473-60E216D9-F41C-4040-A2E8-CF3666DEA3D4Q56909906-2D7EE573-520A-429F-BBC5-934B0CCF1BAA
P2860
Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 May 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cervical cancer screening in l ...... formance and program coverage.
@en
Cervical cancer screening in l ...... formance and program coverage.
@nl
type
label
Cervical cancer screening in l ...... formance and program coverage.
@en
Cervical cancer screening in l ...... formance and program coverage.
@nl
prefLabel
Cervical cancer screening in l ...... formance and program coverage.
@en
Cervical cancer screening in l ...... formance and program coverage.
@nl
P2093
P2860
P356
P1476
Cervical cancer screening in l ...... formance and program coverage.
@en
P2093
Jane J Kim
Nicole G Campos
Philip E Castle
Thomas C Wright
P2860
P304
P356
10.1002/IJC.29594
P577
2015-05-05T00:00:00Z